1. Hoogerwerf, WA, Pasricha, PJ. Agents used for control of gastric acidity and treatment of peptic ulcers and gastroesophageal reflux disease. In: Brunton, L, Lazo, J, Parker, K, eds. Goodman and Gilman’s the pharma- cological basis of therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:1007-1009.
Google Scholar2. Alhazzani, W, Alshahrani, M, Moayyedi, P, Jaeschke, R. Stress ulcer prophylaxis in critically ill patients: review of the evidence. Pol Arch Med Wewn. 2012;122(3):107-114. doi:10.20452/pamw.1173.
Google Scholar | Crossref | Medline3. Young, PJ, Bagshaw, SM, Andrew, FB, The PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group, et al.. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among icu patients receiving invasive mechanical ventilation: The PEPTIC randomized clinical trial. JAMA. 2020;323(7):616-626. doi:10.1001/jama.2019.22190.
Google Scholar | Crossref | Medline4. Watson, TD, Stark, JE, Vesta, KS. Pantoprazole-induced thrombocytopenia. Ann Pharmacother. 2006;40(4):758-761. doi:10.1345/aph.1G384.
Google Scholar | SAGE Journals | ISI5. Binnetoğlu, E, Akbal, E, Şen, H, et al. Pantoprazole-induced thrombocytopenia in patients with upper gastrointestinal bleeding. Platelets. 2015;26(1):10-12. doi:10.3109/09537104.2014.880108.
Google Scholar | Crossref | Medline6. Dotan, E, Katz, R, Bratcher, J, et al. The prevalence of pantoprazole associated thrombocytopenia in a community hospital. Expet Opin Pharmacother. 2007;8(13):2025-2028. doi:10.1517/14656566.8.13.2025.
Google Scholar | Crossref | Medline7. Mukherjee, S, Jana, T, Pan, JJ. Adverse effects of proton pump inhibitors on platelet count: a case report and review of the literature. Case Rep Gastrointest Med 2018;2018:5, 4294805. doi:10.1155/2018/4294805.
Google Scholar | Crossref8. Zlabek, JA, Anderson, CG. Lansoprazole-induced thrombocytopenia. Ann Pharmacother. 2002;36:809-811.
Google Scholar | SAGE Journals | ISI9. Saad, M, Mitwally, H. Lansoprazole-induced thrombocytopenia in a critically Ill patient: A case report. J Pharm Pract. 2020;33(5):700-704.
Google Scholar | SAGE Journals | ISI10. Kallam, A, Abhishek Singla, A, Silberstein, P. Proton pump induced thrombocytopenia: A case report and review of literature. Platelets. 2015;26(6):598-601. doi:10.3109/09537104.2014.953045.
Google Scholar | Crossref | Medline11. Danese, E, Montagnana, M, Favaloro, EJ, Lippi, G. Drug-induced thrombocytopenia: mechanisms and laboratory diagnostics. Semin Thromb Hemost. 2020;46(3):264-274. doi:10.1055/s-0039-1697930.
Google Scholar | Crossref | Medline12. George, JN, Aster, RH. Drug-induced thrombocytopenia: Pathogenesis, evaluation, and management. Hematol Am Soc Hematol Educ Progr 2009;(1):153-158.
Google Scholar | Crossref13. Neunert, C, Lim, W, Crowther, M, et al. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-4207.
Google Scholar | Crossref | Medline | ISI